Grifols launches AlphaID ™, its free oral test that allows the diagnosis of most of the genetic variants that cause alpha-1 antitrypsin deficiency (AATD). AlphaID ™ makes it easy for clinicians to diagnose AATD, the leading known genetic risk factor for chronic obstructive pulmonary disease (COPD).
